HER2+VE Breast Cancer By Adwaita Gore
SESSION 2 : HER2+VE BREAST CANCER
Chairpersons :
Avinash Deo, Vivek Agarwala, Amul Kapoor
Reviewer :
Adwaita Gore
1. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer
Author: Gunter Von Minckwitz
Citation: N Engl J Med 2017; 377:122-131
2. Neratinib after Trastuzumab (T)-based adjuvant therapy in early-stage HER2+ Breast
Cancer (BC): 5-year analysis of the phase III ExteNET trial
Author: Miguel Martin Jimenez
Citation: Annals of Oncology (2017) 28 (suppl_5): v43-v67.ESMO Abstract 149O